Correlation Between Telix Pharmaceuticals and Innovent Biologics
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Innovent Biologics, you can compare the effects of market volatilities on Telix Pharmaceuticals and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Innovent Biologics.
Diversification Opportunities for Telix Pharmaceuticals and Innovent Biologics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Telix and Innovent is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Innovent Biologics go up and down completely randomly.
Pair Corralation between Telix Pharmaceuticals and Innovent Biologics
Assuming the 90 days horizon Telix Pharmaceuticals Limited is expected to generate 0.55 times more return on investment than Innovent Biologics. However, Telix Pharmaceuticals Limited is 1.81 times less risky than Innovent Biologics. It trades about 0.0 of its potential returns per unit of risk. Innovent Biologics is currently generating about -0.13 per unit of risk. If you would invest 1,426 in Telix Pharmaceuticals Limited on August 25, 2024 and sell it today you would lose (16.00) from holding Telix Pharmaceuticals Limited or give up 1.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Telix Pharmaceuticals Limited vs. Innovent Biologics
Performance |
| Timeline |
| Telix Pharmaceuticals |
| Innovent Biologics |
Telix Pharmaceuticals and Innovent Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Telix Pharmaceuticals and Innovent Biologics
The main advantage of trading using opposite Telix Pharmaceuticals and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
| Innovent Biologics vs. Telix Pharmaceuticals Limited | Innovent Biologics vs. Keros Therapeutics | Innovent Biologics vs. MAIA Biotechnology | Innovent Biologics vs. Clarity Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |